CALABRESI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 55.806
AS - Asia 4.862
EU - Europa 3.659
SA - Sud America 699
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 48
OC - Oceania 8
Totale 65.264
Nazione #
US - Stati Uniti d'America 55.675
SG - Singapore 2.414
CN - Cina 967
UA - Ucraina 837
DE - Germania 575
BR - Brasile 573
HK - Hong Kong 555
RU - Federazione Russa 520
IE - Irlanda 468
VN - Vietnam 311
IT - Italia 287
SE - Svezia 244
FR - Francia 229
GB - Regno Unito 175
FI - Finlandia 169
KR - Corea 161
BD - Bangladesh 150
JP - Giappone 107
PL - Polonia 59
CA - Canada 58
AR - Argentina 53
IN - India 39
MX - Messico 28
ID - Indonesia 24
NL - Olanda 24
EU - Europa 19
EC - Ecuador 17
TR - Turchia 17
CL - Cile 15
IQ - Iraq 14
ZA - Sudafrica 14
KG - Kirghizistan 13
ES - Italia 12
SA - Arabia Saudita 11
MA - Marocco 10
UZ - Uzbekistan 10
VE - Venezuela 10
PK - Pakistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
PY - Paraguay 8
UY - Uruguay 8
AU - Australia 7
BE - Belgio 7
CR - Costa Rica 7
LT - Lituania 7
MY - Malesia 7
CO - Colombia 6
DZ - Algeria 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
DM - Dominica 4
HN - Honduras 4
IR - Iran 4
NG - Nigeria 4
RO - Romania 4
TN - Tunisia 4
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
MT - Malta 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
BO - Bolivia 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
Totale 65.091
Città #
Woodbridge 17.722
Wilmington 14.504
Houston 12.885
Fairfield 1.675
Ann Arbor 1.322
Singapore 1.055
Ashburn 799
Jacksonville 776
Seattle 633
Cambridge 574
Hong Kong 549
Dublin 468
San Jose 439
Chandler 408
Medford 328
Beijing 297
Santa Clara 224
The Dalles 193
Lawrence 161
New York 160
Council Bluffs 137
Los Angeles 122
Zhengzhou 120
Mülheim 112
Ho Chi Minh City 104
Menlo Park 102
Buffalo 94
Tokyo 83
Dearborn 82
Moscow 79
Dallas 60
Hanoi 60
Rome 57
San Diego 57
São Paulo 51
Milan 49
Kraków 46
Lauterbourg 40
University Park 39
San Mateo 37
Shanghai 35
Mcallen 32
Hefei 31
Guangzhou 30
Mountain View 29
Orem 29
Falls Church 28
Munich 27
London 26
Verona 26
Saint Petersburg 24
Nanjing 22
Chicago 21
Detroit 19
Redwood City 19
Rio de Janeiro 19
Brooklyn 18
Frankfurt am Main 18
Palo Alto 18
Montreal 17
Norwalk 17
Toronto 15
Redondo Beach 14
Atlanta 13
Brasília 12
Chennai 12
Monmouth Junction 12
North Bergen 12
Redmond 12
San Francisco 12
Da Nang 11
Nuremberg 11
Belo Horizonte 10
Kunming 10
Manchester 10
Nanchang 10
Salvador 10
Warsaw 10
Biên Hòa 9
Columbus 9
Dhaka 9
Haiphong 9
Hangzhou 9
Indiana 9
Johannesburg 9
Miami 9
Boston 8
Jakarta 8
Phoenix 8
Porto Alegre 8
Stockholm 8
Amsterdam 7
Boardman 7
Brno 7
Brussels 7
Cagliari 7
Campinas 7
Can Tho 7
Guayaquil 7
Jinan 7
Totale 57.579
Nome #
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 600
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 554
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 554
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 531
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 524
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 515
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 508
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 499
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 498
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 481
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 479
Muscarinic IPSPs in rat striatal cholinergic interneurones 476
Synaptic transmission in the striatum: from plasticity to neurodegeneration 473
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 471
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 470
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 468
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 467
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 466
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 465
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 463
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 462
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 461
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 460
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 457
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 455
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 455
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 454
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 451
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 451
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 450
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 446
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 446
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 443
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 441
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 440
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 439
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum 437
Hyperkinetic disorders and loss of synaptic downscaling 437
Synaptic plasticity in the ischaemic brain 436
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 436
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 436
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 436
Unilateral dopamine denervation blocks corticostriatal LTP 436
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease 435
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 433
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 433
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 433
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 432
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism 431
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 430
Role of Ca2+ in striatal LTD and LTP 429
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 429
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 428
Removing pathogenic memories: a neurobiology of psychotherapy 428
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 427
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 427
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 427
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease 426
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 426
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 425
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 424
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 424
Tissue plasminogen activator is required for corticostriatal long-term potentiation 424
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 424
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 423
Deficits of glutamate transmission in the striatum of experimental hemiballism 423
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases 423
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 423
Dopaminergic control of synaptic plasticity in the dorsal striatum 423
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 422
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery 421
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 421
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 421
Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors 420
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 420
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 417
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings 417
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 415
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease 415
Permissive role of interneurons in corticostriatal synaptic plasticity 414
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 412
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 409
The modulation of dopamine receptors in rat striatum 409
Basic research in substantia nigra and ventral tegmental area: clinical implications 409
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 408
The modulation of calcium currents by the activation of mGluRs. Functional implications 406
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 405
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses 404
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms 404
NR2B subunit exerts a critical role in postischemic synaptic plasticity 403
Chronic cocaine prevents depotentiation at corticostriatal synapses 403
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 402
Glutamate-triggered events inducing corticostriatal long-term depression 401
Electrophysiology of dopamine in normal and denervated striatal neurons 401
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 401
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease 399
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation 399
Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum 399
Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese 394
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones 394
Totale 44.002
Categoria #
all - tutte 135.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.247 0 71 35 98 16 201 34 51 72 195 38 436
2022/20231.437 190 77 27 138 84 423 157 80 93 4 135 29
2023/2024344 32 13 37 8 32 113 15 27 2 5 0 60
2024/20253.324 83 805 356 189 50 197 240 73 244 191 531 365
2025/20264.548 354 313 514 359 388 134 450 650 493 523 221 149
2026/2027510 255 255 0 0 0 0 0 0 0 0 0 0
Totale 65.264